ABBOTT INDIA
Quarterly Results Analysis [Jun2026]
ABBOTT INDIA Quarterly Results
| Standalone | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹1,814 Cr | ₹1,710 Cr | ₹1,724 Cr | ₹1,757 Cr | ₹1,738 Cr | ₹1,605 Cr | ₹1,614 Cr | ₹1,633 Cr |
| Expenses | ₹1,291 Cr | ₹1,229 Cr | ₹1,261 Cr | ₹1,255 Cr | ₹1,293 Cr | ₹1,176 Cr | ₹1,178 Cr | ₹1,194 Cr |
| Operating Income | ₹523 Cr | ₹481 Cr | ₹463 Cr | ₹502 Cr | ₹446 Cr | ₹429 Cr | ₹436 Cr | ₹439 Cr |
| Other Income | ₹75 Cr | ₹76 Cr | ₹70 Cr | ₹70 Cr | ₹73 Cr | ₹76 Cr | ₹72 Cr | ₹60 Cr |
| Interest | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹8 Cr | ₹6 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr |
| Depreciation | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
| Profit Before Tax | ₹572 Cr | ₹531 Cr | ₹509 Cr | ₹546 Cr | ₹493 Cr | ₹483 Cr | ₹488 Cr | ₹479 Cr |
| Profit After Tax | ₹429 Cr | ₹395 Cr | ₹376 Cr | ₹415 Cr | ₹366 Cr | ₹367 Cr | ₹361 Cr | ₹359 Cr |
| EPS | ₹201.66 | ₹185.85 | ₹176.92 | ₹195.42 | ₹172.17 | ₹172.72 | ₹169.78 | ₹168.76 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ABBOTT INDIA | -2.6% | -8.7% | -21.5% |
| SUN PHARMACEUTICAL INDUSTRIES | 1% | -2.7% | 15.7% |
| DIVIS LABORATORIES | 0.7% | 17.1% | 40.1% |
| TORRENT PHARMACEUTICALS | -0.3% | -3.7% | 37.9% |
| CIPLA | -0.3% | 2.3% | -8.1% |
| DR REDDYS LABORATORIES | -1.4% | 0.7% | -6.2% |
| MANKIND PHARMA | -1.2% | -7.2% | -3.5% |
| LUPIN | -2.9% | -8.5% | 12.4% |
| ZYDUS LIFESCIENCES | -1.1% | 0.6% | 12.1% |
ABBOTT INDIA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 6.09 % |
| Y-o-Y | 4.33 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹1,814 Cr | 6.09 | |
| Mar2026 | ₹1,710 Cr | -0.84 | |
| Dec2025 | ₹1,724 Cr | -1.88 | |
| Sep2025 | ₹1,757 Cr | 1.08 | |
| Jun2025 | ₹1,738 Cr | 8.34 | |
| Mar2025 | ₹1,605 Cr | -0.60 | |
| Dec2024 | ₹1,614 Cr | -1.13 | |
| Sep2024 | ₹1,633 Cr | - | |
ABBOTT INDIA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 8.66 % |
| Y-o-Y | 17.26 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹523 Cr | 8.66 | |
| Mar2026 | ₹481 Cr | 3.75 | |
| Dec2025 | ₹463 Cr | -7.71 | |
| Sep2025 | ₹502 Cr | 12.70 | |
| Jun2025 | ₹446 Cr | 3.98 | |
| Mar2025 | ₹429 Cr | -1.73 | |
| Dec2024 | ₹436 Cr | -0.65 | |
| Sep2024 | ₹439 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 2.42 % |
| Y-o-Y | 12.41 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 28.81% | 2.42 | |
| Mar2026 | 28.13% | 4.65 | |
| Dec2025 | 26.88% | -5.95 | |
| Sep2025 | 28.58% | 11.51 | |
| Jun2025 | 25.63% | -4.04 | |
| Mar2025 | 26.71% | -1.11 | |
| Dec2024 | 27.01% | 0.45 | |
| Sep2024 | 26.89% | - | |
ABBOTT INDIA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 8.51 % |
| Y-o-Y | 17.13 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹429 Cr | 8.51 | |
| Mar2026 | ₹395 Cr | 5.05 | |
| Dec2025 | ₹376 Cr | -9.47 | |
| Sep2025 | ₹415 Cr | 13.51 | |
| Jun2025 | ₹366 Cr | -0.32 | |
| Mar2025 | ₹367 Cr | 1.74 | |
| Dec2024 | ₹361 Cr | 0.61 | |
| Sep2024 | ₹359 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 2.29 % |
| Y-o-Y | 12.26 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 23.63 % | 2.29 | |
| Mar2026 | 23.1 % | 5.91 | |
| Dec2025 | 21.81 % | -7.70 | |
| Sep2025 | 23.63 % | 12.26 | |
| Jun2025 | 21.05 % | -7.96 | |
| Mar2025 | 22.87 % | 2.33 | |
| Dec2024 | 22.35 % | 1.78 | |
| Sep2024 | 21.96 % | - | |
ABBOTT INDIA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 8.51 % |
| Y-o-Y | 17.13 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹201.66 | 8.51 | |
| Mar2026 | ₹185.85 | 5.05 | |
| Dec2025 | ₹176.92 | -9.47 | |
| Sep2025 | ₹195.42 | 13.50 | |
| Jun2025 | ₹172.17 | -0.32 | |
| Mar2025 | ₹172.72 | 1.73 | |
| Dec2024 | ₹169.78 | 0.60 | |
| Sep2024 | ₹168.76 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD